Characteristics of clinician input in Canadian funding decisions for cancer drugs: a cross-sectional study based on CADTH reimbursement recommendations

por Jenei, Kristina, Meyers, Daniel E
Publicado 2023

Assessment of Price and Clinical Benefit of Cancer Drugs in Canada, 2011-2020

por Jenei, Kristina, Meyers, Daniel, Gyawali, Bishal
Publicado 2023

CostPlus and implications for generic imatinib

por Jenei, Kristina, Lythgoe, Mark P., Prasad, Vinay
Publicado 2022

Describing Sources of Uncertainty in Cancer Drug Formulary Priority Setting across Canada

por Jenei, Kristina, Peacock, Stuart, Burgess, Michael, Mitton, Craig
Publicado 2021

What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015–2020)

por Jenei, Kristina, Haslam, Alyson, Olivier, Timothée, Miljkovíc, Milos, Prasad, Vinay
Publicado 2022

Challenges and opportunities for graduate students in public health during the COVID-19 pandemic

por Jenei, Kristina, Cassidy-Matthews, Chenoa, Virk, Punit, Lulie, Bethel, Closson, Kalysha
Publicado 2020

Correction to: Challenges and opportunities for graduate students in public health during the COVID-19 pandemic

por Jenei, Kristina, Cassidy-Matthews, Chenoa, Virk, Punit, Lulie, Bethel, Closson, Kalysha
Publicado 2020

Improving the response to future pandemics requires an improved understanding of the role played by institutions, politics, organization, and governance

por Berman, Peter, Cameron, Maxwell A., Gaurav, Sarthak, Gotsadze, George, Hasan, Md Zabir, Jenei, Kristina, Keidar, Shelly, Kornreich, Yoel, Lovato, Chris, Patrick, David M., Sarker, Malabika, Sosa-Villagarcia, Paolo, Sriram, Veena, Ruck, Candice
Publicado 2023